Ameritas Investment Partners, Inc. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$344,000
+130.9%
5,064
+7.9%
0.02%
+150.0%
Q2 2022$149,000
-8.6%
4,6930.0%0.01%0.0%
Q1 2022$163,000
+19.0%
4,6930.0%0.01%
+20.0%
Q4 2021$137,000
+14.2%
4,6930.0%0.01%
+25.0%
Q3 2021$120,000
-26.8%
4,6930.0%0.00%
-33.3%
Q2 2021$164,000
-38.1%
4,693
-9.4%
0.01%
-60.0%
Q1 2020$265,000
-34.1%
5,178
+2.3%
0.02%
-16.7%
Q4 2019$402,000
+71.8%
5,062
+5.1%
0.02%
+63.6%
Q3 2019$234,000
-3.7%
4,817
+4.1%
0.01%0.0%
Q2 2019$243,000
+3.8%
4,626
+4.8%
0.01%0.0%
Q1 2019$234,000
+41.0%
4,415
+9.0%
0.01%
+22.2%
Q4 2018$166,000
+7.8%
4,0510.0%0.01%
+28.6%
Q3 2018$154,000
-15.8%
4,0510.0%0.01%
-22.2%
Q2 2018$183,000
+16.6%
4,051
+25.0%
0.01%
+12.5%
Q1 2018$157,000
+22.7%
3,2410.0%0.01%
+33.3%
Q4 2017$128,000
+30.6%
3,2410.0%0.01%
+20.0%
Q3 2017$98,000
+10.1%
3,2410.0%0.01%
+25.0%
Q2 2017$89,000
+41.3%
3,241
+90.3%
0.00%
+33.3%
Q1 2017$63,0001,7030.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders